be_ixf;ym_202212 d_04; ct_50

Guadalupe Regional Medical Center COVID-19 Update – January 20, 2022

GRMC is currently caring for 26 COVID patients in addition to our non-COVID census.

GRMC Statistics: The 7-day moving average for COVID hospitalizations is 24 per day and the 7- day moving average for new COVID admissions is 6 per day. The positivity rate of COVID-19 tests run through GRMC’s laboratory remains high indicating presumed continued community spread of the Omicron variant.

COVID-19 Testing Options: The GRMC Emergency Department continues to see a significant number of asymptomatic persons presenting for COVID-19 testing. If you have no symptoms requiring emergency care, GRMC encourages you to find and visit testing sites near you by visiting https://www.dshs.state.tx.us/coronavirus/testing.aspx and click on “Covid-19 testing near me”. To receive up to 4 free at-home COVID-19 tests visit https://www.covidtests.gov/.

GRMC Resources: GRMC has received 8 STRAC personnel to assist with the current inpatient increase. GRMC has just received another shipment of Sotrovimab, a new monoclonal therapy thought to work best on patients with illness from the COVID-19 Omicron variant. Medication shortages continue to impact healthcare delivery nationwide and GRMC is not immune to these issues.

GRMC’s Regional Infusion Center: Guadalupe Regional Medical Center continues to host a State operated regional infusion center for delivery of monoclonal antibody infusion to persons with active COVID-19 disease. Over the last week, the center has averaged 25 infusions per day. The COVID-19 Omicron variant antibody treatment supply is severely limited in the U.S. and locally which requires that those at highest risk for hospitalization and/or progression to severe disease from COVID-19 be prioritized for infusion. Infusions are for treatment of active COVID-19 disease and should not be confused with the protective effect of vaccination.

On December 22, the FDA authorized the emergency use of the first oral antiviral treatment for COVID-19, Paxlovid. Paxlovid, as well as some other antivirals are available for the treatment of COVID-19 infection. These medications require an order from a licensed care provider and can be purchased at local retail pharmacies where available.

Stay Informed: Guadalupe Regional Medical Center is committed to providing our community with updated information as warranted during this challenging time.

For further information, please visit our website at www.grmedcenter.com

More from GRMC